Return to Library
Hyperthyroidism (overactive thyroid) and pregnancy Visual Overview
Topic

Hyperthyroidism (overactive thyroid) and pregnancy

💡 What You Need to Know

  • Understanding Hyperthyroidism in Pregnancy: Hyperthyroidism, or an overactive thyroid, occurs when the thyroid gland produces too much thyroid hormone.
  • Prevalence and Causes: Affects approximately 0.1% to 0.4% of pregnancies, with Graves' disease being the most common cause (90-95% of cases).
  • Maternal Risks: Uncontrolled hyperthyroidism can lead to preeclampsia, heart failure, thyroid storm, and miscarriage.
  • Fetal and Neonatal Risks: Potential for preterm birth, low birth weight, fetal growth restriction, stillbirth, and neonatal thyroid dysfunction.
  • Importance of Management: Early diagnosis and careful management are crucial for optimal maternal and fetal outcomes.

🤒 Associated Symptoms

  • Increased Heart Rate: Experiencing a persistent resting heart rate over 100 beats per minute, often accompanied by palpitations.
  • Heat Intolerance and Sweating: Feeling unusually warm, even in cool environments, and excessive sweating.
  • Unexplained Weight Loss: Losing weight despite maintaining or increasing food intake, which can be concerning during pregnancy.
  • Tremor and Nervousness: Fine tremor in the hands, anxiety, irritability, and difficulty sleeping.
  • Fatigue and Muscle Weakness: Despite increased metabolism, profound fatigue and muscle weakness can be prominent.
  • Goiter: A visible or palpable enlargement of the thyroid gland in the neck.

🛡 Crucial Precautions

  • Regular Thyroid Function Monitoring: Adhere strictly to scheduled blood tests (TSH, free T4, free T3) to adjust medication dosages as needed throughout pregnancy.
  • Antithyroid Medication Adherence: Take prescribed antithyroid drugs (e.g., Propylthiouracil (PTU) in the first trimester, Methimazole (MMI) in the second and third trimesters) exactly as directed.
  • Avoidance of Radioactive Iodine: Radioactive iodine therapy (RAI) is absolutely contraindicated during pregnancy and breastfeeding due to its harmful effects on the fetal thyroid gland.
  • Beta-Blocker Use: Discuss the safe use of beta-blockers for symptom control (e.g., tachycardia) with your physician, as some are preferred over others in pregnancy.
  • Monitoring for Thyroid Storm: Be vigilant for signs of thyroid storm, a life-threatening complication, including high fever, severe tachycardia, altered mental status, and vomiting.
  • Postpartum Monitoring: Thyroid function often changes postpartum; continued monitoring and medication adjustments are essential.

🍽 Dietary Directions & Restrictions

  • Iodine Intake Management: Avoid excessive iodine intake from supplements, kelp products, or certain medications, as it can exacerbate hyperthyroidism.
  • Adequate Hydration: Maintain good hydration with water and electrolyte-rich fluids, especially given increased metabolic rate and potential for sweating.
  • Nutrient-Dense Foods: Focus on a balanced diet rich in fruits, vegetables, lean proteins, and whole grains to support overall health and manage increased energy demands.
  • Avoidance of Iodine-Rich Foods (in excess): While not a strict restriction, discuss with your doctor if you consume large amounts of iodine-rich foods like seaweed or certain seafood.
  • Calcium and Vitamin D: Ensure adequate intake of calcium and vitamin D, as hyperthyroidism can sometimes affect bone density.

⚠️ Attendant Guidelines

  • Report New or Worsening Symptoms: Immediately inform your healthcare provider of any new symptoms or worsening of existing hyperthyroid symptoms.
  • Medication Consistency: Do not stop or alter your antithyroid medication dosage without explicit instruction from your endocrinologist or obstetrician.
  • Emergency Signs: Seek immediate medical attention for severe palpitations, shortness of breath, high fever, confusion, or persistent vomiting, as these could indicate thyroid storm.
  • Preconception Counseling: If planning pregnancy, seek preconception counseling to optimize thyroid status before conception.
  • Breastfeeding Considerations: Discuss safe antithyroid medication options and dosages with your doctor if you plan to breastfeed.

🩺 Physician's Perspective

  • Multidisciplinary Care: Emphasize the importance of a collaborative approach involving an endocrinologist, obstetrician, and potentially a perinatologist.
  • Individualized Treatment Plans: Stress that treatment must be tailored to the individual patient, considering the severity of hyperthyroidism, gestational age, and response to therapy.
  • Fetal Surveillance: Recommend regular fetal growth scans and monitoring for signs of fetal thyroid dysfunction (e.g., fetal tachycardia, goiter).
  • Postpartum Management: Advise on the high risk of postpartum thyroid dysfunction and the need for continued follow-up after delivery.
  • Genetic Counseling: Consider genetic counseling if Graves' disease is present, due to potential for fetal/neonatal Graves' disease.

🎓 Academic & Nursing Corner

  • Patient Education: Educate patients on medication adherence, symptom recognition, and the importance of regular follow-up appointments.
  • Vital Sign Monitoring: Closely monitor maternal vital signs, especially heart rate and blood pressure, noting any deviations.
  • Medication Administration: Understand the specific antithyroid drugs used in pregnancy, their dosages, and potential side effects.
  • Recognizing Complications: Be alert for signs and symptoms of thyroid storm, preeclampsia, and other pregnancy complications.
  • Postpartum Care: Provide guidance on postpartum thyroid monitoring and breastfeeding considerations for mothers on antithyroid medications.

🔬 Clinical Reference Index

  • Diagnostic Criteria: Diagnosis relies on suppressed TSH levels and elevated free T4 and/or free T3 levels. Thyroid-stimulating immunoglobulins (TSI) are crucial for diagnosing Graves' disease.
  • Differential Diagnosis: Differentiate from gestational transient thyrotoxicosis (GTT), which typically resolves by mid-pregnancy and does not require antithyroid drugs.
  • Treatment Modalities: Antithyroid drugs (ATDs) are the primary treatment. PTU is preferred in the first trimester due to lower teratogenic risk, while MMI is preferred in the second and third trimesters.
  • Monitoring Parameters: Regular monitoring includes TSH, free T4, free T3, and complete blood count (CBC) and liver function tests (LFTs) due to potential ATD side effects.
  • Surgical Intervention: Thyroidectomy is rarely considered during pregnancy, typically only for severe cases unresponsive to ATDs or with significant adverse reactions.